You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Drug Price Trends for CETIRIZINE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CETIRIZINE HCL

Average Pharmacy Cost for CETIRIZINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CETIRIZINE HCL 1 MG/ML SOLN 45802-0626-26 0.02147 ML 2025-03-19
CETIRIZINE HCL 5 MG TABLET 16571-0401-10 0.05182 EACH 2025-03-19
CETIRIZINE HCL 1 MG/ML SOLN 00121-0874-04 0.02147 ML 2025-03-19
CETIRIZINE HCL 1 MG/ML SOLN 51672-2102-08 0.03371 ML 2025-03-19
CETIRIZINE HCL 1 MG/ML SOLN 45802-0974-26 0.03737 ML 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CETIRIZINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CETIRIZINE HCL 1MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 51672-4070-08 120ML 3.50 0.02917 ML 2024-01-01 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Cetirizine Hydrochloride Market Analysis and Price Projections

Introduction to Cetirizine Hydrochloride

Cetirizine hydrochloride is a second-generation antihistamine widely used to treat various allergic conditions, including allergic rhinitis, allergic conjunctivitis, and urticaria (hives). It is marketed under several brand names, such as Zyrtec and Aller-Tec, and is available in various forms including tablets, capsules, and oral solutions[3].

Global Market Size and Growth

The global cetirizine hydrochloride market has been steadily growing due to the increasing prevalence of allergic diseases. In 2017, the market size was valued at US$ 1,100 million and was expected to grow at a CAGR of 3.2% from 2018 to 2026[1].

By 2024, the market size had expanded significantly, with a valuation of US$ 6.3 billion. It is projected to grow at a CAGR of 2.6% to reach US$ 8.0 billion by 2034[3].

Key Drivers of Market Growth

Increasing Prevalence of Allergic Conditions

The rising incidence of allergic rhinitis, allergic conjunctivitis, and eczema is a major driver of the cetirizine hydrochloride market. According to the American Academy of Allergy Asthma and Immunology, allergic rhinitis affects around 10% to 30% of the global population, with the highest prevalence in North America[1].

Demographic and Economic Factors

The market is also driven by demographic factors such as an aging population and increasing disposable income, particularly in the Asia Pacific region. The growing financial burden of allergic diseases on the affected population in regions like North America further contributes to market growth[3].

Regional Market Insights

North America

North America holds a dominant position in the global cetirizine hydrochloride market due to the high prevalence of hay fever and allergic conjunctivitis in the U.S. The region is expected to continue its significant growth due to the increasing economic burden of allergic diseases[1].

Asia Pacific

The Asia Pacific region is anticipated to witness the fastest revenue growth, driven by an aging population, greater disposable income, and rising allergy awareness. Developing nations in this region offer considerable market potential for cetirizine hydrochloride[3].

Europe and Other Regions

Europe's market is expanding steadily due to its aging population and the rise in allergy prevalence among senior citizens. Latin America and the Middle East & Africa are emerging regions with growing healthcare spending and government initiatives to enhance drug access and allergy awareness[3].

Market Segmentation

The cetirizine hydrochloride market is segmented based on type (capsules, tablets, solutions) and application (hospitals, clinics, drug stores). The introduction of generic versions has increased competition, leading to lower prices and greater accessibility across various socioeconomic backgrounds[3][4].

Price Projections and Affordability

Current Pricing

The cost of cetirizine hydrochloride varies depending on the form and quantity. For example, a supply of 30 tablets of 10 mg oral cetirizine can cost around $11, while the oral liquid form can range from $19.16 for 118 milliliters to $48.79 for 480 milliliters[5].

Future Pricing Trends

Given the projected market growth and increasing competition from generic versions, prices are likely to remain competitive. However, the introduction of new products and formulations could influence pricing dynamics. For instance, the launch of convenient oral, dissolvable tablets by McNeil Consumer Healthcare in 2014 exemplifies how innovation can impact market pricing and consumer preference[1].

Challenges and Restraints

Despite the growth potential, the cetirizine hydrochloride market faces challenges such as the development of new medications that could slow its growth rate. Additionally, stringent regulatory laws and the potential for side effects (e.g., insomnia, hyperactivity, uneven heartbeat) can limit market adoption[1][3].

Key Players and Competitive Landscape

Major players in the global cetirizine hydrochloride market include Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd. These companies are focused on new product launches and expanding their market share through strategic initiatives[1].

Conclusion

The cetirizine hydrochloride market is poised for continued growth driven by the increasing prevalence of allergic conditions, demographic changes, and economic factors. While challenges such as new medication development and regulatory hurdles exist, the market's potential remains robust, especially in regions like North America and the Asia Pacific.

Key Takeaways

  • The global cetirizine hydrochloride market is expected to grow from US$ 6.3 billion in 2024 to US$ 8.0 billion by 2034.
  • The market is driven by the increasing incidence of allergic conditions and demographic factors.
  • North America and the Asia Pacific are key regions driving market growth.
  • The market faces challenges from new medication development and regulatory constraints.
  • Major players are focusing on new product launches to enhance market share.

Frequently Asked Questions (FAQs)

1. What is cetirizine hydrochloride used for?

Cetirizine hydrochloride is used to treat allergic conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria (hives).

2. What is the current market size of the cetirizine hydrochloride market?

As of 2024, the global cetirizine hydrochloride market was valued at US$ 6.3 billion.

3. What is the projected growth rate of the cetirizine hydrochloride market?

The market is projected to grow at a CAGR of 2.6% from 2024 to 2034.

4. Which regions are driving the growth of the cetirizine hydrochloride market?

North America and the Asia Pacific are the key regions driving market growth due to high prevalence rates and demographic factors.

5. What are the main challenges facing the cetirizine hydrochloride market?

The main challenges include the development of new medications, stringent regulatory laws, and potential side effects of the drug.

Sources:

  1. Coherent Market Insights - Global Cetirizine Hydrochloride Market Size And Forecast To 2026[1]
  2. Biospace - Cetirizine Hydrochloride Market Key Players, Sales, Demand, Dynamic Forces, and Forecast 2029[2]
  3. Prophecy Market Insights - Global Cetirizine Hydrochloride Market By Overview[3]
  4. Cognitive Market Research - Cetirizine Hydrochloride Market Report 2024 (Global Edition)[4]
  5. Drugs.com - Cetirizine Prices, Coupons, Copay Cards & Patient Assistance[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.